Table 2. Adjusted odds ratio of mortality outcomes according to eGFR categories.
| Mortality | eGFR categories | ||||
|---|---|---|---|---|---|
| ≥60 | 45–59 | 30–44 | 15–29 | <15/dialysis | |
| Worst | |||||
| In-hospital | reference | 0.96 (0.53, 1.75) | 1.11 (0.64, 1.91) | 2.04 (1.19, 3.48) | 4.79 (2.88, 7.95) |
| 28-day | reference | 1.14 (0.73, 1.79) | 0.99 (0.66, 1.51) | 2.09 (1.40, 3.12) | 3.42 (2.27, 5.15) |
| 1-year | reference | 1.05 (0.81, 1.36) | 1.26 (0.99, 1.61) | 1.96 (1.53, 2.53) | 2.58 (1.96, 3.38) |
| Last | |||||
| In-hospital | reference | 0.72 (0.44, 1.18) | 1.22 (0.79, 1.90) | 2.10 (1.35, 3.26) | 4.99 (3.30, 7.56) |
| 28-day | reference | 0.87 (0.59, 1.27) | 1.25 (0.89, 1.77) | 2.06 (1.45, 2.92) | 3.66 (2.55, 5.25) |
| 1-year | reference | 0.99 (0.79, 1.24) | 1.29 (1.04, 1.60) | 1.60 (1.26, 2.04) | 2.30 (1.76, 3.00) |
Adjusted for primary covariates: age, race, gender, health insurance, diabetes, hypertension, smoke, history of coronary heart disease, heart failure type (preserved vs. reduced ejection fraction), and chronic obstructive pulmonary disease.